Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Incyte Corporation INCY

Healthcare  —  Biotechnology
123.36 (1.46) (1.17%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Incyte Corporation (INCY) Return on invested capital

Incyte Corporation's return on invested capital over the twelve months to 30 June 2026 was 60.5%, up 1.9 percentage points from fiscal 2025 (58.6%). Over the past ten years it has ranged from −31.4% (fiscal 2017) to 58.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2025 58.6% 55.65
FY2024 2.90% (21.91)
FY2023 24.8% (6.08)
FY2022 30.9% 5.92
FY2021 25.0% 44.19
FY2020 −19.2% (66.53)
FY2019 47.3% 31.32
FY2018 16.0% 47.36
FY2017 −31.4% (65.91)
FY2016 34.5% (3.72)

Against its own ten years

Low −31.4% High 58.6%
Ten-year median 25.0%
Current reading's percentile 100

Return on invested capital against peers

Company Return on invested capital
INCY Incyte Corporation 60.5%
ONC BeOne Medicines Ltd. - Sponsored ADR compare 60.2%
JAZZ Jazz Pharmaceuticals PLC compare 8.06%
GMAB Genmab A/S Sponsored ADR compare 6.99%
RPRX Royalty Pharma PLC compare 5.28%
ALNY Alnylam Pharmaceuticals, Inc. compare 0.00%
ROIV Roivant Sciences Ltd. compare −34.5%
BNTX BioNTech SE Sponsored ADR compare −38.4%
INSM Insmed, Inc. compare −329.2%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on INCY